Draxis, Merck deal

DRAXF signed a letter of intent to acquire Merck Frosst

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE